Hydrazine hydrate (1:1) → 3-(4-Bromophenyl)-1,9-dimethyl-6-(2H-pyrazol-3-yl)-1,9-dihydropyrido[2,3-b]indol-2-one
Reaktionsgleichung
[Br:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:28](=[O:29])[N:27]([CH3:30])[C:11]3[N:12]([CH3:26])[C:13]4[C:18]([C:10]=3[CH:9]=2)=[CH:17][C:16]([C:19](=O)[CH:20]=[CH:21][N:22](C)C)=[CH:15][CH:14]=4)=[CH:4][CH:3]=1.O.[NH2:32]N>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[C:28](=[O:29])[N:27]([CH3:30])[C:11]3[N:12]([CH3:26])[C:13]4[C:18]([C:10]=3[CH:9]=2)=[CH:17][C:16]([C:19]2[NH:32][N:22]=[CH:21][CH:20]=2)=[CH:15][CH:14]=4)=[CH:6][CH:7]=1Komponenten
3
Versuchsvorschrift
The process is carried out as indicated in Example 36 above, with compound 3-(4-bromophenyl)-6-(3-dimethylaminoacryloyl)-1,9-dimethyl-1,9-dihydropyrido[2,3-b]indol-2-one and hydrazine monohydrate.
Quellen und Nachweise
- ORD-Eintrag
- ord-1486cab25c0440b993fda0458205969d
- Quelldatensatz
- uspto-grants-2011_11